Mirabella Financial Services LLP Vertex Pharmaceuticals Inc Transaction History

Mirabella Financial Services LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $9.5 Million - $10.2 Million	-28,089 Reduced 96.74%	946 $328,000
Q2 2023 Aug 07, 2023	BUY	$314.42 - $351.91 $9.13 Million - $10.2 Million	29,035 New	29,035 $10.2 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $575,417 - $716,454	-2,449 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$221.42 - $260.97 $542,257 - $639,115	2,449 New	2,449 $639,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.